Home / M&A Activity / SAIC Completes Sale of Test and Evaluation Business to AMERICAN SYSTEMS; Bill Hoover Comments

SAIC Completes Sale of Test and Evaluation Business to AMERICAN SYSTEMS; Bill Hoover Comments

Bill Hoover

Science Applications International Corp. (NYSE: SAI) has completed the sale of its test and evaluation business to AMERICAN SYSSTEMS Corp. and the terms of the sale were not disclosed, according to a Washington Technology article.

AMERICAN SYSTEMS said the acquisition will help its work with the Defense Information Systems Agency’s joint interoperability test command.

(Click Here, to read the original GovCon Wire article about the deal published in September.)

“The Test & Evaluation market traditionally experiences remarkable growth as conflicts are winding down, ” said Bill Hoover, AMERICAN SYSTEMS president and CEO in a statement.

“Innovative technologies developed to support various divisions of our military now need to achieve interoperability, he added.

“We see this area as a huge growth opportunity for American Systems.”

According to the Nick Wakeman article, the deal was first announced in September, shortly after SAIC announced its decision to split into two businesses.

The investment bank Houlihan Lokey acted as SAIC’s advisor in the sale and according to its officials, the transaction “serves as further evidence of ongoing strategic portfolio shaping initiatives occurring across the industry, including divestitures, carve-outs and spinoffs.”

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.